17-1709535-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001164407.2(TLCD2):āc.306G>Cā(p.Leu102Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000041 in 1,536,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001164407.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLCD2 | NM_001164407.2 | c.306G>C | p.Leu102Phe | missense_variant | 3/4 | ENST00000330676.8 | NP_001157879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLCD2 | ENST00000330676.8 | c.306G>C | p.Leu102Phe | missense_variant | 3/4 | 2 | NM_001164407.2 | ENSP00000331965 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152070Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000139 AC: 2AN: 144338Hom.: 0 AF XY: 0.0000259 AC XY: 2AN XY: 77082
GnomAD4 exome AF: 0.0000440 AC: 61AN: 1384924Hom.: 0 Cov.: 33 AF XY: 0.0000454 AC XY: 31AN XY: 683390
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152070Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74278
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.306G>C (p.L102F) alteration is located in exon 3 (coding exon 3) of the TLCD2 gene. This alteration results from a G to C substitution at nucleotide position 306, causing the leucine (L) at amino acid position 102 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at